Mitral valve prolapse is a benign condition. Mitral regurgitation is only complicated in patients with severe mitral valve prolapse. Women with mitral valve prolapse in the absence of other cardiovascular disorders tolerate pregnancy well and do not develop remarkable cardiac complications. Nevertheless, serious complications of mitral valve prolapse, including arrhythmia, infective endocarditis and cerebral ischemic events, can be present in pregnancy. Debates remain with regard to the use of prophylactic antibiotics and β-blockers in the pregnant women with mitral valve prolapse. The prognosis of the pregnant patients might be closely related to the pathological and (or) functional changes of the mitral valve. Non-myxomatous mitral valve prolapse poses no or little obstetric risks in terms of pregnancy, labor and neonatal complications; whereas myxomatous mitral valve prolapse is a major etiology of valvular heart disease in women of childbearing age. In the pregnant patients with mitral valve prolapse progressing into major complications, surgical interventions are considered. Medicinal treatment of such patients with β-blockers should be a concern for the fetal safety.
Čtyřcípá aortální chlopeň se vyskytuje vzácně. Sedmačtyřicetiletá žena si stěžovala na mírnou dušnost při zátěži a byla odeslána do naší nemocnice. Transthorakální echokardiografi e prokázala čtyřcípou aortální chlopeň s mírnou aortální insufi ciencí. Při kontrolním vyšetření po devíti měsících se ženě vedlo dobře, bez progrese výše popsaného mírného symptomu. V tomto článku je popsán velmi vzácný případ čtyřcípé aortální chlopně typu D. Transthorakální echokardiografi e může poskytnout přesné anatomické informace o čtyřcípé aortální chlopni. Při mírných symptomech je nutno pacienty pravidelně sledovat.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.